159 related articles for article (PubMed ID: 23324405)
1. Evolution of novel tricyclic CRTh2 receptor antagonists from a (E)-2-cyano-3-(1H-indol-3-yl)acrylamide scaffold.
Valdenaire A; Pothier J; Renneberg D; Riederer MA; Peter O; Leroy X; Gnerre C; Fretz H
Bioorg Med Chem Lett; 2013 Feb; 23(4):944-8. PubMed ID: 23324405
[TBL] [Abstract][Full Text] [Related]
2. Identification of 2-(2-(1-naphthoyl)-8-fluoro-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)acetic acid (setipiprant/ACT-129968), a potent, selective, and orally bioavailable chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2) antagonist.
Fretz H; Valdenaire A; Pothier J; Hilpert K; Gnerre C; Peter O; Leroy X; Riederer MA
J Med Chem; 2013 Jun; 56(12):4899-911. PubMed ID: 23721423
[TBL] [Abstract][Full Text] [Related]
3. Novel 2-(2-(benzylthio)-1H-benzo[d]imidazol-1-yl)acetic acids: discovery and hit-to-lead evolution of a selective CRTh2 receptor antagonist chemotype.
Pothier J; Riederer MA; Peter O; Leroy X; Valdenaire A; Gnerre C; Fretz H
Bioorg Med Chem Lett; 2012 Jul; 22(14):4660-4. PubMed ID: 22726929
[TBL] [Abstract][Full Text] [Related]
4. Azaindoles as potent CRTH2 receptor antagonists.
Simard D; Leblanc Y; Berthelette C; Zaghdane MH; Molinaro C; Wang Z; Gallant M; Lau S; Thao T; Hamel M; Stocco R; Sawyer N; Sillaots S; Gervais F; Houle R; Lévesque JF
Bioorg Med Chem Lett; 2011 Jan; 21(2):841-5. PubMed ID: 21185722
[TBL] [Abstract][Full Text] [Related]
5. 2-(1H-Pyrazol-1-yl)acetic acids as chemoattractant receptor-homologous molecule expressed on Th2 lymphocytes (CRTh2) antagonists.
Andrés M; Bravo M; Buil MA; Calbet M; Castillo M; Castro J; Eichhorn P; Ferrer M; Lehner MD; Moreno I; Roberts RS; Sevilla S
Eur J Med Chem; 2014 Jan; 71():168-84. PubMed ID: 24292338
[TBL] [Abstract][Full Text] [Related]
6. 2-(1H-Pyrazol-4-yl)acetic acids as CRTh2 antagonists.
Andrés M; Bravo M; Buil MA; Calbet M; Castro J; Domènech T; Eichhorn P; Ferrer M; Gómez E; Lehner MD; Moreno I; Roberts RS; Sevilla S
Bioorg Med Chem Lett; 2013 Jun; 23(11):3349-53. PubMed ID: 23601708
[TBL] [Abstract][Full Text] [Related]
7. Verification of the Major Metabolic Oxidation Path for the Naphthoyl Group in Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells (CRTh2) Antagonist 2-(2-(1-Naphthoyl)-8-fluoro-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)acetic Acid (Setipiprant/ACT-129968).
Risch P; Pfeifer T; Segrestaa J; Fretz H; Pothier J
J Med Chem; 2015 Oct; 58(20):8011-35. PubMed ID: 26398218
[TBL] [Abstract][Full Text] [Related]
8. 3-Indolyl sultams as selective CRTh2 antagonists.
Tumey LN; Robarge MJ; Gleason E; Song J; Murphy SM; Ekema G; Doucette C; Hanniford D; Palmer M; Pawlowski G; Danzig J; Loftus M; Hunady K; Sherf B; Mays RW; Stricker-Krongrad A; Brunden KR; Bennani YL; Harrington JJ
Bioorg Med Chem Lett; 2010 Jun; 20(11):3287-90. PubMed ID: 20457519
[TBL] [Abstract][Full Text] [Related]
9. Switching between agonists and antagonists at CRTh2 in a series of highly potent and selective biaryl phenoxyacetic acids.
Luker T; Bonnert R; Schmidt J; Sargent C; Paine SW; Thom S; Pairaudeau G; Patel A; Mohammed R; Akam E; Dougall I; Davis AM; Abbott P; Brough S; Millichip I; McInally T
Bioorg Med Chem Lett; 2011 Jun; 21(12):3616-21. PubMed ID: 21592791
[TBL] [Abstract][Full Text] [Related]
10. Solving time-dependent CYP3A4 inhibition for a series of indole-phenylacetic acid dual antagonists of the PGD(2) receptors CRTH2 and DP.
Johnson MG; Liu JJ; Li AR; van Lengerich B; Wang S; Medina JC; Collins TL; Danao J; Seitz L; Willee A; D'Souza W; Budelsky AL; Fan PW; Wong SG
Bioorg Med Chem Lett; 2014 Jul; 24(13):2877-80. PubMed ID: 24825301
[TBL] [Abstract][Full Text] [Related]
11. Identification of prostaglandin D2 receptor antagonists based on a tetrahydropyridoindole scaffold.
Beaulieu C; Guay D; Wang Z; Leblanc Y; Roy P; Dufresne C; Zamboni R; Berthelette C; Day S; Tsou N; Denis D; Greig G; Mathieu MC; O'Neill G
Bioorg Med Chem Lett; 2008 Apr; 18(8):2696-700. PubMed ID: 18359630
[TBL] [Abstract][Full Text] [Related]
12. 2-Cycloalkyl phenoxyacetic acid CRTh2 receptor antagonists.
Sandham DA; Aldcroft C; Baettig U; Barker L; Beer D; Bhalay G; Brown Z; Dubois G; Budd D; Bidlake L; Campbell E; Cox B; Everatt B; Harrison D; Leblanc CJ; Manini J; Profit R; Stringer R; Thompson KS; Turner KL; Tweed MF; Walker C; Watson SJ; Whitebread S; Willis J; Williams G; Wilson C
Bioorg Med Chem Lett; 2007 Aug; 17(15):4347-50. PubMed ID: 17531480
[TBL] [Abstract][Full Text] [Related]
13. Discovery of selective indole-based prostaglandin D₂ receptor antagonist.
Iwahashi M; Shimabukuro A; Onoda T; Matsunaga Y; Okada Y; Matsumoto R; Nambu F; Nakai H; Toda M
Bioorg Med Chem; 2011 Aug; 19(15):4574-88. PubMed ID: 21737285
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships (SAR) and structure-kinetic relationships (SKR) of bicyclic heteroaromatic acetic acids as potent CRTh2 antagonists II: lead optimization.
Alonso JA; Andrés M; Bravo M; Calbet M; Eastwood PR; Eichhorn P; Esteve C; Ferrer M; Gómez E; González J; Mir M; Moreno I; Petit S; Roberts RS; Sevilla S; Vidal B; Vidal L; Vilaseca P; Zanuy M
Bioorg Med Chem Lett; 2014 Nov; 24(21):5123-6. PubMed ID: 25437505
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a new class of potent, selective, and orally bioavailable CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseases.
Crosignani S; Page P; Missotten M; Colovray V; Cleva C; Arrighi JF; Atherall J; Macritchie J; Martin T; Humbert Y; Gaudet M; Pupowicz D; Maio M; Pittet PA; Golzio L; Giachetti C; Rocha C; Bernardinelli G; Filinchuk Y; Scheer A; Schwarz MK; Chollet A
J Med Chem; 2008 Apr; 51(7):2227-43. PubMed ID: 18318469
[TBL] [Abstract][Full Text] [Related]
16. Isoquinoline derivatives as potent CRTH2 receptor antagonists: synthesis and SAR.
Nishikawa-Shimono R; Sekiguchi Y; Koami T; Kawamura M; Wakasugi D; Watanabe K; Wakahara S; Matsumoto K; Takayama T
Bioorg Med Chem Lett; 2012 May; 22(9):3305-10. PubMed ID: 22469703
[TBL] [Abstract][Full Text] [Related]
17. Indole-3-acetic acid antagonists of the prostaglandin D2 receptor CRTH2.
Armer RE; Ashton MR; Boyd EA; Brennan CJ; Brookfield FA; Gazi L; Gyles SL; Hay PA; Hunter MG; Middlemiss D; Whittaker M; Xue L; Pettipher R
J Med Chem; 2005 Oct; 48(20):6174-7. PubMed ID: 16190744
[TBL] [Abstract][Full Text] [Related]
18. Identification of an indole series of prostaglandin D2 receptor antagonists.
Sturino CF; Lachance N; Boyd M; Berthelette C; Labelle M; Li L; Roy B; Scheigetz J; Tsou N; Brideau C; Cauchon E; Carriere MC; Denis D; Greig G; Kargman S; Lamontagne S; Mathieu MC; Sawyer N; Slipetz D; O'Neill G; Wang Z; Zamboni R; Metters KM; Young RN
Bioorg Med Chem Lett; 2006 Jun; 16(11):3043-8. PubMed ID: 16529930
[TBL] [Abstract][Full Text] [Related]
19. Discovery of a potent and selective prostaglandin D2 receptor antagonist, [(3R)-4-(4-chloro-benzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]-acetic acid (MK-0524).
Sturino CF; O'Neill G; Lachance N; Boyd M; Berthelette C; Labelle M; Li L; Roy B; Scheigetz J; Tsou N; Aubin Y; Bateman KP; Chauret N; Day SH; Lévesque JF; Seto C; Silva JH; Trimble LA; Carriere MC; Denis D; Greig G; Kargman S; Lamontagne S; Mathieu MC; Sawyer N; Slipetz D; Abraham WM; Jones T; McAuliffe M; Piechuta H; Nicoll-Griffith DA; Wang Z; Zamboni R; Young RN; Metters KM
J Med Chem; 2007 Feb; 50(4):794-806. PubMed ID: 17300164
[TBL] [Abstract][Full Text] [Related]
20. 7-Azaindole-3-acetic acid derivatives: potent and selective CRTh2 receptor antagonists.
Sandham DA; Adcock C; Bala K; Barker L; Brown Z; Dubois G; Budd D; Cox B; Fairhurst RA; Furegati M; Leblanc C; Manini J; Profit R; Reilly J; Stringer R; Schmidt A; Turner KL; Watson SJ; Willis J; Williams G; Wilson C
Bioorg Med Chem Lett; 2009 Aug; 19(16):4794-8. PubMed ID: 19592244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
